LONDON, Aug 3, 2021 - (ACN Newswire) - The ClinTex (CTi) tokenized platform (clintex.io
) will be the first of its kind to utilize blockchain-based clinical data analytics to address the main causes of
clinical trial inefficiency, helping to drive down the cost of new medicines and expediting their delivery to patients.ClinTex launches 'Operational Excellence' - a blockchain clinical trial application to tackle clinical trial
inefficiencies and high costs.
The initial spark of an idea that would eventually become ClinTex started in 2014, at the DIA Forum in Vienna. By 2018,
Clintex was formally working on the Clinical Trials Intelligence (CTi) platform. CTi's purpose is to deliver data
analysis at scale, to drive collaboration and insights across clinical trials.
With large pharma companies like Merck and Novartis already testing blockchain as a technology of the future to support
their clinical trial strategy for patient information and to manage clinical trial medication, this paves the way for
ClinTex CTi to partner with the industry to deliver more innovative and impactful uses of blockchain to increase
clinical trial efficiency.
The CTi-OEM App
Leveraging 50+ years of medicine development experience, ClinTex has moved at a breakneck pace to launch its first
blockchain clinical trial app of the CTi Platform, the Operational Excellence Module (CTi-OEM). CTi-OEM provides
intuitive operational oversight of clinical trials for clinical project managers, clinical data managers and remote
staff; allowing in-stream decision-making on what actions are required to ensure a successful investigation into the
safety and efficacy of new medicines.
Using the CTi-OEM console, researchers can deep dive into clinical trial data and take proactive action to make clinical
trials run more efficiently. These operational issues include things like clinical protocol deviations and adverse
events relating to patient safety in the clinical trial.
The company has prioritized the development of the CTi-OEM blockchain clinical trial app to target some of the major
causes of inefficiency in clinical trials, enabling its first app to derive maximum tangible benefits for the pharma and
clinical trials industry. CTi-OEM achieves this through a comprehensive portfolio of tools, which is accessible through
the CTi-OEM console.
One of the major obstacles to a successful clinical trial is adherence to the clinical trial protocol. Analytics within
the CTi-OEM application allows the detection and analysis of these deviations and allows the clinical trial team to take
speedy action. These tools provide powerful insights into the major causes of non-compliance in clinical trials
providing analytics to help clinical trial teams identify and resolve them to speed up progress.
Protecting patient safety during a clinical trial is the most important aspect in the development of any new medicine.
Adverse events are safety issues that occur during the testing of a new medicine. CTi-OEM provides valuable insight into
patient safety throughout a clinical trial. For example, adverse event rate per site allows the clinical trial team to
identify those sites that have a high rate of safety events which may point to procedural problems or may also uncover
safety risks that need further investigation.
These are just a few examples of CTi-OEM's toolkit. For more information on CTi-OEM, there is a series of demonstration
videos that give an overview of the platform, and how it can help alleviate pain points in clinical trials.
The First App of Many
CTi-OEM is just the beginning of Clintex's offerings. Eventually, it will consist of 7 different blockchain clinical
trial applications that derive intelligent analytics from all types of clinical trial data, and it is these analytics
that can be used to drive efficiency in clinical trials. The ClinTex roadmap is on track to have live client onboarding
and revenue generation by the end of 2022.
Any clinical trial professionals interested in becoming early adopters can email ClinTex at firstname.lastname@example.org
or visit http://clinicaltrialsintelligence.org